Multiple Sclerosis Treatment Developed in Australia Shows Promise

Australian researchers have made a breakthrough in the treatment of Multiple Sclerosis using immunotherapy. Their world-first trial has produced promising results for the majority of patients enrolled, they said, including a reduction in fatigue and improvements in mobility and vision.

Multiple sclerosis as seen on MRI. Image credit: James Heilman, MD/Wikipedia (CC BY-SA 4.0)

The treatment targets the Epstein-Barr virus in the brain that Australian researchers believe plays a role in the development of Multiple Sclerosis, or MS, a disease of the central nervous system. Immune cells extracted from patients’ blood have been “trained” in a laboratory to recognize and destroy the virus.

“What happens in MS, there is an immune reaction going on in your brain that is represented as if that your immune system is attacking the brain cells,” said Rajiv Khanna, a professor at Queensland’s QIMR Berghofer Medical Research Institute. “Once that happens, your normal function in the brain gets impaired. We are trying to develop a treatment that could actually, sort of, make the immune system to work properly rather than going in the wrong direction.”

Researchers hope the treatment could stop the progression of MS. They say the trial is significant because they have shown the technique is safe and has had positive improvements in an autoimmune disease.

Seven of the 10 participants in the Queensland trial have reported positive changes, including Louise Remmerswaal, a mother from Queensland.

“Ever since the trial, it has just improved so much that now I can go out and spend time with my family and friends,” she said.

Further research is planned in Australia and the United States.

The new therapy is developed by the QIMR Berghofer Medical Research Institute in Brisbane and the University of Queensland.

The results of the clinical trial have been published in the peer-reviewed journal, JCI Insight. (VOA)

YOU MAY ALSO LIKE

Oxygen can impair cancer immunotherapy in mice

Researchers have identified a mechanism in mice by which anticancer immune responses are inhibited within the lungs, a common site of metastasis for many cancers.

Cambridge scientists reverse ageing process in rat brain stem cells

New research reveals how increasing brain stiffness as we age causes brain stem cell dysfunction, and demonstrates new ways to reverse older stem cells to a younger, healthier state.

Tell-tale biomarker detects early breast cancer

Researchers have shown that magnetic resonance imaging can detect the earliest signs of breast cancer recurrence and fast-growing tumors. Their approach detects micrometastases, breakaway tumor cells with the potential to develop into dangerous secondary breast cancer tumors elsewhere in the body. The approach may offer an improved way to detect early recurrence of breast cancer in women and men.

Study finds link between long-term exposure to air pollution and emphysema

Long-term exposure to air pollution was linked to increases in emphysema between 2000 and 2018, according to a new study.

Tumor DNA in Blood Reveals Lymphoma Progression

Using an advanced genetic test, researchers were able to detect diffuse large B-cell lymphoma (DLBCL) in blood serum before it could be seen on CT scans.

Molecule may impact Gaucher, Parkinson’s disease

Scientists identified a molecule that restores the activity of a dysfunctional enzyme tied to both Gaucher disease and Parkinson’s disease. These findings suggest a new avenue to explore for treating these disorders.